NUVA NuVasive, Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

NUVA [NASD]

NuVasive, Inc.

Healthcare | Medical Devices | USA

statements

Index	-	P/E	48.09	EPS (ttm)	1.14	Insider Own	0.20%	Shs Outstand	51.84M	Perf Week	-4.12%
Market Cap	2.74B	Forward P/E	22.42	EPS next Y	2.44	Insider Trans	-5.65%	Shs Float	50.91M	Perf Month	-12.39%
Income	61.10M	PEG	5.52	EPS next Q	-0.55	Inst Own	-	Short Float	13.42%	Perf Quarter	-6.35%
Sales	1.15B	P/S	2.38	EPS this Y	414.80%	Inst Trans	0.38%	Short Ratio	7.53	Perf Half Y	-31.33%
Book/sh	17.10	P/B	3.20	EPS next Y	222.03%	ROA	3.20%	Target Price	67.19	Perf Year	-4.23%
Cash/sh	10.22	P/C	5.36	EPS next 5Y	8.71%	ROE	6.90%	52W Range	28.55 - 81.91	Perf YTD	-29.23%
Dividend	-	P/FCF	27.74	EPS past 5Y	40.30%	ROI	7.00%	52W High	-33.18%	Beta	1.36
Dividend %	-	Quick Ratio	0.90	Sales past 5Y	8.90%	Gross Margin	73.10%	52W Low	91.70%	ATR	2.82
Employees	2800	Current Ratio	1.40	Sales Q/Q	-5.40%	Oper. Margin	11.40%	RSI (14)	46.50	Volatility	4.97% 5.07%
Optionable	Yes	Debt/Eq	1.12	EPS Q/Q	-44.90%	Profit Margin	5.30%	Rel Volume	0.49	Prev Close	53.53
Shortable	Yes	LT Debt/Eq	0.41	Earnings	May 06 AMC	Payout	0.00%	Avg Volume	907.36K	Price	54.73
Recom	2.40	SMA20	-2.56%	SMA50	-7.19%	SMA200	-15.66%	Volume	446,710	Change	2.24%

Jun-25-20

Initiated

Northland Capital

Market Perform

$65

Jun-23-20

Upgrade

Needham

Hold → Buy

Apr-08-20

Upgrade

Robert W. Baird

Neutral → Outperform

$66

Mar-05-20

Initiated

Citigroup

Neutral

$68

Jan-08-20

Initiated

SunTrust

Buy

$93

Dec-13-19

Upgrade

SVB Leerink

Mkt Perform → Outperform

Jul-29-19

Downgrade

Robert W. Baird

Outperform → Neutral

$66

Feb-12-19

Downgrade

Jefferies

Buy → Hold

$60

Feb-08-19

Downgrade

Needham

Buy → Hold

Oct-31-18

Reiterated

Needham

Buy

$80 → $75

Oct-17-18

Reiterated

Needham

Buy

$67 → $80

Sep-27-18

Upgrade

Robert W. Baird

Neutral → Outperform

Aug-01-18

Reiterated

Needham

Buy

$69 → $67

Jun-27-18

Downgrade

BofA/Merrill

Neutral → Underperform

Jun-21-18

Downgrade

JP Morgan

Overweight → Neutral

Jun-01-18

Initiated

Cantor Fitzgerald

Neutral

May-02-18

Reiterated

Needham

Buy

$70 → $69

Apr-04-18

Initiated

Goldman

Neutral

$47

Feb-27-18

Reiterated

Needham

Buy

$71 → $70

Feb-01-18

Downgrade

Leerink Partners

Outperform → Mkt Perform

Jun-22-20 11:08AM	NuVasive Launches Reline 3D for Pediatric Patients Globally Zacks
09:24AM	Here's Why You Should Hold on to NuVasive (NUVA) Stock Now Zacks
Jun-18-20 08:33AM	NuVasive Expands Complex Spine Portfolio with Global Launch of Reline 3D for Pediatric Deformity PR Newswire
Jun-15-20 06:01PM	Edited Transcript of NUVA earnings conference call or presentation 6-May-20 8:30pm GMT Thomson Reuters StreetEvents
05:40PM	Nuvasive Shows Improved Relative Price Performance; Still Shy Of Benchmark Investor's Business Daily
03:05PM	NuVasive, Inc. (NUVA): Hedge Funds Taking Some Chips Off The Table Insider Monkey
Jun-05-20 11:31AM	NuVasive (NUVA) Up 6.6% Since Last Earnings Report: Can It Continue? Zacks +7.64%
10:53AM	DLA Piper advises NuVasive in its US$400 million convertible senior notes offering PR Newswire
Jun-04-20 04:10PM	NuVasive, Inc. Announces Full Exercise Of Option By Initial Purchasers To Purchase Additional 1.00% Convertible Senior Notes Due 2023 PR Newswire
May-28-20 12:18AM	NuVasive, Inc. Announces Pricing Of Offering Of $400 Million Of 1.00% Convertible Senior Notes Due 2023 PR Newswire
May-26-20 04:02PM	NuVasive, Inc. Announces Proposed Offering Of $400 Million Of Convertible Senior Notes Due 2023 PR Newswire
May-19-20 08:33AM	NuVasive LessRay® Platform Wins Best New Imaging Technology Solution in 2020 MedTech Breakthrough Awards PR Newswire
May-12-20 04:03PM	NuVasive to Participate in UBS Virtual Global Healthcare Conference PR Newswire -5.34%
May-11-20 09:28AM	New Strong Sell Stocks for May 11th Zacks
May-07-20 04:00PM	NuVasive Inc (NUVA) Q1 2020 Earnings Call Transcript Motley Fool
10:53AM	NuVasive's (NUVA) Q1 Earnings Beat Estimates, Revenues Miss Zacks
May-06-20 06:35PM	NuVasive (NUVA) Beats Q1 Earnings and Revenue Estimates Zacks
04:02PM	NuVasive Announces First Quarter 2020 Financial Results PR Newswire
May-05-20 08:33AM	NuVasive Expands Advanced Materials Science Implant Portfolio to Additional Thoracolumbar Procedures PR Newswire
May-04-20 04:03PM	NuVasive to Participate in BofA Securities 2020 Healthcare Conference PR Newswire
Apr-29-20 12:34PM	Analysts Estimate NuVasive (NUVA) to Report a Decline in Earnings: What to Look Out for Zacks +5.69%
Apr-16-20 08:36AM	NuVasive (NUVA) Posts Q1 Preliminary Results, Withdraws View Zacks
Apr-14-20 04:02PM	NuVasive Provides Business Update Related to COVID-19 PR Newswire
Apr-13-20 07:24AM	A Rising Share Price Has Us Looking Closely At NuVasive, Inc.'s (NASDAQ:NUVA) P/E Ratio Simply Wall St. -5.48%
Apr-06-20 04:14PM	Dayton stocks reap massive gains as broad market skyrockets American City Business Journals +6.62%
Apr-05-20 07:36PM	Hedge Funds Are Buying NuVasive, Inc. (NUVA) Insider Monkey
Apr-01-20 03:00PM	Dayton stocks dive again after Q1 registers biggest drop since 2008 American City Business Journals -11.45%
Mar-24-20 05:09PM	These Dayton stocks skyrocketed as market posts best day since 1933 American City Business Journals +17.25%
11:24AM	A Sliding Share Price Has Us Looking At NuVasive, Inc.'s (NASDAQ:NUVA) P/E Ratio Simply Wall St.
Mar-23-20 11:24AM	Here's Why You Should Hold on to NuVasive (NUVA) Stocks Now Zacks
Mar-10-20 11:22AM	What Is NuVasive's (NASDAQ:NUVA) P/E Ratio After Its Share Price Tanked? Simply Wall St.
08:33AM	Randomized Controlled Trial Results Published in 'Spine' Demonstrate Efficacy of NuVasive Attrax® Putty in Posterolateral Lumbar Fusion PR Newswire
Mar-09-20 09:20AM	Allscripts' Veradigm Business Line Unveils New Solution Zacks -10.18%
Mar-02-20 08:33AM	NuVasive to Participate at Spine Summit 2020 PR Newswire
Feb-28-20 02:53PM	Dayton stocks face sharp declines as equity market tumbles American City Business Journals
Feb-27-20 04:03PM	NuVasive to Participate in Cowen 40th Annual Healthcare Conference PR Newswire
02:11AM	NuVasive, Inc. Announces Pricing Of Offering Of $450 Million Of 0.375% Convertible Senior Notes Due 2025 PR Newswire
12:32AM	Edited Transcript of NUVA earnings conference call or presentation 20-Feb-20 9:30pm GMT Thomson Reuters StreetEvents
Feb-26-20 08:05AM	NuVasive, Inc. Announces Proposed Offering Of $450 Million Of Convertible Senior Notes Due 2025 PR Newswire
Feb-23-20 09:09AM	Results: NuVasive, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates Simply Wall St.
Feb-21-20 08:32AM	NuVasive (NUVA) Earnings and Revenues Beat Estimates in Q4 Zacks
Feb-20-20 04:02PM	NuVasive Announces Fourth Quarter and Full Year 2019 Financial Results PR Newswire
Feb-13-20 08:33AM	Results Validating the Versatility of NuVasive's MaXcess® Retractor in Prone Single-Position XLIF® and Posterior Fixation Published in The European Spine Journal PR Newswire
Feb-11-20 08:30AM	NuVasive, Inc.s (NASDAQ:NUVA) Investment Returns Are Lagging Its Industry Simply Wall St.
Feb-04-20 04:03PM	NuVasive Announces Conference Call and Webcast of Fourth Quarter and Full Year 2019 Results PR Newswire
Jan-24-20 09:55AM	What's in Store for IDEXX Laboratories' (IDXX) Q4 Earnings? Zacks
Jan-23-20 08:23AM	What's in Store for Align Technology's (ALGN) Q4 Earnings? Zacks
Jan-20-20 12:10PM	Can NuVasive (NUVA) Keep the Earnings Surprise Streak Alive? Zacks
09:13AM	Can Abbott (ABT) Q4 Earnings Ride on Growth in All Lines? Zacks
Jan-16-20 10:01AM	NuVasive (NUVA) Stock Dips Despite Strong Preliminary Q4 Show Zacks
Jan-15-20 10:50AM	Nuvasive Earns Membership In 95-Plus Composite Rating Club Investor's Business Daily
Jan-14-20 04:41AM	Can Focus on High-Growth Area Up OrganiGram (OGI) Q1 Earnings? Zacks
03:59AM	Can Focus on High-Growth Area Up OrganiGram (OGI) Q1 Earnings? Zacks
Jan-13-20 10:16AM	Can New Strategic Efforts Aid Apharia's (APHA) Q2 Earnings? Zacks
08:33AM	NuVasive Announces Preliminary Unaudited Fourth Quarter and Full Year 2019 Revenue Results PR Newswire
08:14AM	Can Cannabis Therapy Drive Aphria's (APHA) Q2 Earnings? Zacks
Jan-10-20 11:32AM	Why NuVasive, Inc. (NASDAQ:NUVA) Could Be Worth Watching Simply Wall St.
Jan-09-20 08:39AM	The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, DBV Announces Positive Peanut Allergy Study Findings, Applied Genetic Soars On Trial Results Benzinga
Jan-08-20 01:28PM	NuVasive Is 'A Stock To Watch For In 2020,' SunTrust Says In Bullish Initiation Benzinga
Jan-06-20 04:03PM	NuVasive to Participate in 38th Annual J.P. Morgan Healthcare Conference PR Newswire
Jan-03-20 07:55AM	The Daily Biotech Pulse: Acorda Surges As Point72 Hikes Stake, Novan Sinks On Failed Study, Illumina-Pac Bio Terminate Merger Benzinga
Jan-02-20 04:01PM	NuVasive Appoints Matthew K. Harbaugh as Chief Financial Officer PR Newswire
Dec-30-19 11:47AM	Bio-Rad Gains on New Product Portfolio Despite Currency Woes Zacks
10:17AM	Here's Why You Should Add NuVasive Stock to Your Portfolio Zacks
09:31AM	Syneos Health (SYNH) Hits a 52-Week High: What's Driving It? Zacks
Dec-27-19 12:05PM	Edwards (EW) Rides on Innovation Despite Regulatory Issues Zacks
11:40AM	NUVA vs. RMD: Which Stock Is the Better Value Option? Zacks
10:26AM	Here's Why You Should Hold on to Thermo Fisher Stock for Now Zacks
10:16AM	Here's Why You Should Hold on to Hill-Rom (HRC) Stock Now Zacks
Dec-26-19 11:42AM	Strong Pipeline Aids Tandem Diabetes Despite Stiff Rivalry Zacks
10:06AM	Nevro (NVRO) Hits New 52-Week High: What's Driving the Stock? Zacks
Dec-24-19 09:28AM	Zimmer Biomet Hits New 52-Week High: What's Driving It? Zacks
09:02AM	6 MedTech Stocks That are Set to Beat the Market in 2020 Zacks
Dec-23-19 09:15AM	NuVasive (NUVA) Soars to 52-Week High, Time to Cash Out? Zacks
Dec-19-19 09:19AM	Here's Why You Should Hold on to Globus Medical Stock for Now Zacks
08:38AM	Buy These 5 Stocks With Upgraded Broker Ratings for 2020 Zacks
Dec-18-19 09:43AM	Here's Why You Should Retain Integra LifeSciences Stock Now Zacks
Dec-17-19 10:04AM	Insulet Rides on Innovation, Omnipod's Wider Market Appeal Zacks
08:22AM	ResMed (RMD) Hits a 52-Week High: What's Driving the Stock? Zacks
08:22AM	Cardiovascular Systems Sees Peripheral OAS Micro Crown Success Zacks
Dec-16-19 11:22AM	Tandem Diabetes Gets FDA Nod for t:slim X2 Insulin Pump Zacks
Dec-13-19 09:08AM	Neogen's Food Safety Business Thrives on Ergot Alkaloids Test Zacks
Dec-12-19 10:25AM	Intersect ENT (XENT) Grows on Innovation Despite Cost Woes Zacks
10:22AM	Walgreens Extends Deal to Form GPO With Retail Giant Kroger Zacks
08:06AM	Here's Why You Should Hold on to Quest Diagnostics Stock Now Zacks
07:22AM	Here's Why You Should Add Omnicell to Your Portfolio Now Zacks
Dec-11-19 08:42AM	How Does NuVasive, Inc. (NASDAQ:NUVA) Affect Your Portfolio Volatility? Simply Wall St.
Dec-10-19 06:38AM	Omnicell (OMCL) Partners With Kit Check to Offer Bluesight Zacks
Dec-09-19 11:40AM	NUVA vs. HAE: Which Stock Should Value Investors Buy Now? Zacks
10:05AM	Edwards Lifesciences (EW) Plans Strong Long-Term TAVR Growth Zacks
10:01AM	Amedisys (AMED) Benefits From Home Health and Personal Care Zacks
09:18AM	Thermo Fisher (TMO) at a 52-Week High: What's Driving It? Zacks
09:01AM	NuVasive Hits New 52-Week High: What's Driving the Stock? Zacks
Dec-08-19 04:25PM	Heres What Hedge Funds Think About NuVasive, Inc. (NUVA) Insider Monkey
Dec-06-19 09:25AM	NuVasive (NUVA) Hits 52-Week High, Can the Run Continue? Zacks
Dec-05-19 09:24AM	Myriad Genetics Reports Favorable Study Result on Prequel Zacks
07:39AM	Boston Scientific's Watchman Implant Study Results Encourage Zacks
Dec-04-19 09:57AM	NuVasive Advances on Global Footprint Despite Pricing Woes Zacks
09:55AM	Illumina Inks Deal With ArcherDX to Deliver NGS-Based IVD Kits Zacks
09:12AM	Haemonetics (HAE) Launches SafeTrace Tx in North America Zacks

NuVasive, Inc., a medical device company, develops and markets minimally disruptive surgical products and procedurally integrated solutions for spine surgery. Its products focus on applications for spine fusion surgery, including ancillary products and services used to aid in the surgical procedure. The company's principal products include Maximum Access Surgery, a minimally disruptive surgical platform, which includes its software-driven nerve detection and avoidance systems, and intraoperative monitoring (IOM) services and support; MaXcess, an integrated split-blade retractor system; and various specialized implants and biologics. Its spine surgery product line offerings comprises products for the thoracolumbar and the cervical spine, which are primarily used to enable surgeons to access the spine to perform restorative and fusion procedures in a minimally disruptive fashion. The company's biologics products include Osteocel Plus and Pro, a cellular bone matrix; Formagraft, a collagen-based synthetic bone substitute; AttraX, a synthetic bone graft material; and Propel DBM, a moldable demineralized bone matrix putty and gel. Its IOM services are used for onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also provides implants used for interbody disc height restoration; and fixation products, including pedicle screws, rods, and plates. In addition, it offers Integrated Global Alignment platform for assessing, preserving, and restoring spinal alignment; MAGEC-early onset scoliosis, a spinal bracing and distraction system; and Precice, a limb lengthening system. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly-employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was founded in 1997 and is headquartered in San Diego, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Link Matthew	President	Jun 08	Sale	67.00	3,000	201,000	82,595	Jun 10 05:52 PM
Vitale Lucas	Chief Human Resources Officer	Mar 01	Option Exercise	0.00	1,652	0	7,483	Mar 03 05:53 PM
SISITSKY NATHANIEL	SVP & General Counsel	Mar 01	Option Exercise	0.00	1,586	0	10,952	Mar 03 05:51 PM
Link Matthew	President	Mar 01	Option Exercise	0.00	7,929	0	88,010	Mar 03 05:48 PM
LUCIER GREGORY T	Director	Mar 01	Option Exercise	0.00	33,695	0	235,915	Mar 03 05:44 PM
Link Matthew	President	Jan 16	Sale	79.80	3,000	239,400	80,081	Jan 17 05:53 PM
Link Matthew	President	Dec 24	Option Exercise	43.88	12,760	559,921	91,708	Dec 27 05:49 PM
Link Matthew	President	Dec 24	Sale	77.38	3,500	270,830	78,948	Dec 27 05:49 PM
LUCIER GREGORY T	Director	Nov 18	Sale	72.99	29,469	2,150,836	202,220	Nov 20 05:49 PM
McClintock Paul	President, U.S. Commercial	Nov 11	Sale	72.04	3,314	238,741	400	Nov 13 05:51 PM
Barry James Christopher	Chief Executive Officer	Nov 05	Option Exercise	0.00	17,944	0	17,944	Nov 07 05:41 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience